Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-21 Purchase |
2024-05-23 4:33 pm |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
15,000 | $16.98 | $254,700 | 76,330 (Direct) |
View |
| 2024-03-08 Purchase |
2024-03-12 4:32 pm |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
15,000 | $16.3 | $244,500 | 61,330 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:44 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
837 | $69.66 | $58,305 | 551,176 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-09 4:48 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
2,385 | $70.1 | $167,189 | 552,013 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:01 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
995 | $149.38 | $148,631 | 554,398 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 6:29 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
95,000 | $199.55 | $18,957,452 | 555,393 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 4:14 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
7,928 | $134.12 | $1,063,303 | 650,393 (Direct) |
View |
| 2020-07-31 Sale |
2020-08-03 5:51 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
896 | $76.39 | $68,444 | 649,062 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-12 4:13 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
31,332 | $63.73 | $1,996,726 | 649,958 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-11 4:17 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
62,896 | $64.11 | $4,032,390 | 740,057 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:41 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
60,164 | $63.36 | $3,812,170 | 920,489 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-29 Option Award |
2024-12-03 5:12 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
18,169 | $0 | 94,499 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:31 pm |
N/A 2034-05-30 |
PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director |
62,558 | $0 | 62,558 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 5:33 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
20,374 | $0 | 46,330 (Direct) |
View |
| 2023-06-29 Option Award |
2023-07-03 09:15 am |
N/A 2033-06-29 |
PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director |
48,128 | $0 | 48,128 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 5:10 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
18,649 | $0 | 25,956 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 9:27 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director |
3,028,652 | $0 | 3,028,652 (Direct) |
View |
Ownership |
2022-07-13 9:13 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director |
0 | $0 | 0 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-28 7:35 pm |
N/A 2032-06-09 |
Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director |
2,500 | $0 | 2,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:21 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
14,581 | $80.59 | 14,581 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:11 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director |
7,307 | $0 | 7,307 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:49 pm |
N/A 2031-06-10 |
Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-02 4:14 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
9,259 | $125.25 | 650,393 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-02 4:14 pm |
2019-03-31 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
9,259 | $0 | 650,393 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:57 pm |
N/A 2030-06-10 |
Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 07:53 am |
N/A 2030-06-09 |
OptiNose Inc. | OPTN | DOYLE WILLIAM F Director |
14,439 | $5.65 | 14,439 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,767 | $63.84 | 740,057 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:17 pm |
2020-05-07 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
117,535 | $0 | 740,057 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $64.77 | 740,057 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:41 pm |
2020-05-06 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
117,536 | $0 | 920,489 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $64.15 | 920,489 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $61.4 | 920,489 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 5:52 pm |
2020-05-04 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $0 | 804,350 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 5:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $60.48 | 804,350 (Direct) |
View |